VAKSINASI MASAL COVID-19 DI UNIVERSITAS MUHAMMADIYAH MATARAM KOTA MATARAM PROVINSI NUSA TENGGARA BARAT

Authors

  • Evi Diliana Rospia UNIVERSITAS MUHAMMADIYAH MATARAM
  • Dwi Kartika Cahyaningtyas Universitas Muhammadiyah Mataram
  • Desi Rofita Universitas Muhammadiyah Mataram
  • Cahaya Indah Lestari Universitas Muhammadiyah Mataram
  • Ni Wayan Ari Adi Putri Universitas Muhammadiyah Mataram
  • Baiq Masdariah Universitas Muhammadiyah Mataram
  • Hofifah Hofifah Universitas Muhammadiyah Mataram
  • Annisatul Islami Universitas Muhammadiyah Mataram

DOI:

https://doi.org/10.31764/jpmb.v5i1.6094

Keywords:

vaccination, covid-19, community, indonesia.

Abstract

ABSTRAK

Novel coronavirus 2019 atau virus corona sindrom pernafasan akut parah yang disebut COVID-19. Gejala klinis utama yang muncul yaitu demam, batuk dan kesulitan bernapas. World Health Organization (WHO) melaporkan 11.84.226 kasus konfirmasi dengan 545.481 kematian di seluruh dunia (Case Fatality Rate/CFR 4,6%). Di Indonesia kasus meningkat dan menyebar dengan cepat, kasus pertama pada tanggal 2 Maret 2020, pada tanggal 9 Juli 2020 Kementerian Kesehatan melaporkan 70.736 kasus konfirmasi COVID-19 dengan 3.417 kasus meninggal (CFR 4,8%). Kegiatan vaksinasi masal ini bertujuan terbentuknya herd immunity (kekebalan kelompok) dan berkurangnya angka kematian akibat COVID-19 pada masyarakat. Kegiatan vaksinasi masal dilaksanakan di Universitas Muhammadiyah Mataram Kota Mataram Nusa Tenggara Barat, dan jenis vaksin yang digunakan pada kegiatan vaksinasi masal ini adalah Sinovac. Jumlah responden yang mengikuti kegiatan ini sebanyak 1.000 orang. Hasil pengabdian didapatkan jumlah yang melakukan vaksinasi sebanyak 1000 orang yang terdiri dari masyarakat umum dan karyawan Universitas Muhammadiyah Mataram.

 

Kata kunci: vaksinasi; covid-19; komunitas; indonesia.

 

ABSTRACT

Novel coronavirus 2019 or severe acute respiratory syndrome coronavirus called COVID-19. The main symptoms that appear are fever, cough and difficulty breathing. The World Health Organization (WHO) reports 11,84,226 confirmed cases with 545,481 deaths worldwide (Case Fatality Rate/CFR 4.6%) In Indonesia cases are increasing and spreading rapidly, the first case on March 2, 2020, on July 9 2020 The Ministry of Health reported 70,736 confirmed cases of COVID-19 with 3,417 deaths (CFR 4.8%). This mass vaccination activity aims to form herd immunity and reduce the death rate due to COVID-19 in the community. The mass vaccination activity was carried out at the Muhammadiyah University of Mataram, and the type of vaccine used in this mass vaccination activity was Sinovac. The number of respondents who participated in this activity was 1,000 people. The results of the service found that the number of people who vaccinated was 1000 people consisting of the general public and employees of the Muhammadiyah University of Mataram.

 

Keywords: vaccination; covid-19; community; indonesia.

 

References

Amit, S., Regev-Yochay, G., Afek, A., Kreiss, Y., & Leshem, E. (2021). Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. The Lancet, 397(10277), 875–877. https://doi.org/10.1016/S0140-6736(21)00448-7

Affandi, A., Sarwani, A. S., Erlangga, H., Siagian, A. O., Purwanto, A., Effendy, A. A,& Wahyitno, C. D. M. (2020). Optimization of MSMEs Empowerment in Facing Competition in the Global Market during the COVID-19 Pandemic Time. Systematic Reviews in Pharmacy, 11(11), 1506-1515.

Dagan, N., Barda, N., Kepten, E., Miron, O., Perchik, S., Katz, M. A., Hernán, M. A., Lipsitch, M., Reis, B., & Balicer, R. D. (2021). BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. New England Journal of Medicine, 384(15), 1412–1423. https://doi.org/10.1056/nejmoa2101765

Hall, V. J., Foulkes, S., Saei, A., Andrews, N., Oguti, B., Charlett, A., Wellington, E., Stowe, J., Gillson, N., Atti, A., Islam, J., Karagiannis, I., Munro, K., Khawam, J., Chand, M. A., Brown, C. S., Ramsay, M., Lopez-Bernal, J., Hopkins, S., … Heeney, J. L. (2021). COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. The Lancet, 397(10286), 1725–1735. https://doi.org/10.1016/S0140-6736(21)00790-X

Kementerian Kesehatan RI. 2020. Available at https://sehatnegeriku.kemkes.go.id/baca/rilismedia/20211011/2138708/vaksinasi-covid-19-di-indonesia-tembus-100-juta-orang/

Satgas COVID-19. Pengendalian COVID-19 Dengan 3M,3T, Vaksinasi, Disiplin, Kompak, dan Konsisten Buku 2. Jakarta: Satuan Satgas COVID-19.

Tjandra Yoga Aditama. 2020. COVID-19. Jakarta: Lembaga Penerbit Badan Penelitian dan Pengembangan

World Health Organization, (WHO) (2020) Coronavirus, World Health Organization. Available at: https://www.who.int/health-topics/coronavirus#tab=tab_1

Downloads

Published

2021-12-10

Issue

Vol. 5 No. 1 (2021): Desember

Section

Articles

License

The copyright of the received article shall be assigned to the journal as the publisher of the journal. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.


Creative Commons License
Selaparang : Jurnal Pengabdian Masyarakat Berkemajuan is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.